Table 1

Baseline characteristics of participants in the NAFLD and non-NAFLD groups

NAFLD group (n = 728)Non-NAFLD group (n = 2,346)
Age (years)43.8 ± 7.343.0 ± 7.2
Male:female sex611:1171,255:1,091
BMI (kg/m2)26.0 ± 2.921.8 ± 2.5
Aspartate aminotransferase (units/L)27.7 ± 11.920.3 ± 5.7
Alanine aminotransferase (units/L)40.7 ± 24.320.0 ± 10.9
GGT (units/L)66.8 ± 71.533.6 ± 35.7
Bilirubin (mg/dL)0.77 ± 0.350.75 ± 0.32
Albumin (g/dL)4.4 ± 0.24.3 ± 0.2
Platelet count (× 109/L)231 ± 50225 ± 48
Fasting plasma glucose (mg/dL)99.1 ± 9.394.0 ± 8.6
HbA1c (%)5.3 ± 0.35.1 ± 0.3
HbA1c (mmol/mol)34 ± 3.332 ± 3.3
IFG336 (46.1)533 (22.7)
Family history of diabetes127 (17.4)320 (13.6)
DL480 (65.9)619 (26.4)
Triglycerides (mg/dL)146.1 ± 126.187.0 ± 50.9
HDL cholesterol (mg/dL)50.3 ± 11.161.5 ± 15.0
LDL cholesterol (mg/dL)136.0 ± 30.7116.6 ± 27.7
Lipid-lowering drug30 (4.1)29 (1.2)
HT145 (19.9)196 (8.4)
Systolic blood pressure (mmHg)122.4 ± 13.3115.6 ± 14.0
Diastolic blood pressure (mmHg)80.2 ± 9.874.6 ± 10.2
Antihypertensive drug41 (5.6)56 (2.4)
Current smoker270 (40.4)750 (34.7)
Physical exercise81 (11.1)377 (16.1)
  • Data are mean ± SD or n (%) unless otherwise indicated.